Byrne Asset Management LLC Jazz Pharmaceuticals PLC Transaction History

Byrne Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$115.19 - $132.77 $2,534 - $2,920	-22 Reduced 70.97%	9 $1,000
Q4 2023 Jan 29, 2024	SELL	$114.26 - $136.0 $1,713 - $2,040	-15 Reduced 32.61%	31 $3,000
Q4 2022 Jan 30, 2023	SELL	$129.72 - $159.85 $1,297 - $1,598	-10 Reduced 17.86%	46 $7,000
Q3 2022 Oct 19, 2022	SELL	$126.59 - $161.18 $6,329 - $8,059	-50 Reduced 47.17%	56 $7,000
Q2 2022 Jul 20, 2022	SELL	$141.59 - $168.66 $10,477 - $12,480	-74 Reduced 41.11%	106 $17,000
Q4 2021 Feb 22, 2022	BUY	$119.87 - $145.67 $21,576 - $26,220	180 New	180 $23,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Byrne Asset Management LLC with notifications on news.